<code id='0EB5F24989'></code><style id='0EB5F24989'></style>
    • <acronym id='0EB5F24989'></acronym>
      <center id='0EB5F24989'><center id='0EB5F24989'><tfoot id='0EB5F24989'></tfoot></center><abbr id='0EB5F24989'><dir id='0EB5F24989'><tfoot id='0EB5F24989'></tfoot><noframes id='0EB5F24989'>

    • <optgroup id='0EB5F24989'><strike id='0EB5F24989'><sup id='0EB5F24989'></sup></strike><code id='0EB5F24989'></code></optgroup>
        1. <b id='0EB5F24989'><label id='0EB5F24989'><select id='0EB5F24989'><dt id='0EB5F24989'><span id='0EB5F24989'></span></dt></select></label></b><u id='0EB5F24989'></u>
          <i id='0EB5F24989'><strike id='0EB5F24989'><tt id='0EB5F24989'><pre id='0EB5F24989'></pre></tt></strike></i>

          knowledge

          knowledge

          author:Wikipedia    Page View:9
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Pediatricians' group reaffirms support for gender
          Pediatricians' group reaffirms support for gender

          Aprotestorwearsatransgenderflagatahearingonbanninggender-affirminghealthcarelegislationinMissouri.AP

          read more
          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more

          Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

          DarronCummings/APThebenefitsandrisksofEliLilly’streatmentforAlzheimer’sdiseasewereconfirmedindetaile